COMMUNIQUÉS West-GlobeNewswire

IBEX Reports First Quarter Fiscal 2018 Results

15/12/2017 - 14:00

MONTREAL, Dec. 15, 2017 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture:IBT) today reported its financial results for the quarter ended October 31, 2017. “Revenues and earnings for the [...]

Surgery Partners, Inc. Announces $50.0 Million Share Repurchase Program

15/12/2017 - 14:00

BRENTWOOD, Tenn., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that its Board of Directors has [...]

Extendicare Announces December 2017 Dividend of C$0.04 per Share

15/12/2017 - 14:00

MARKHAM, Ontario, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]

American Health Council Names Leslie Fletcher, BSN, RN, MEP-C to Nursing Board

15/12/2017 - 14:00

NEW YORK, Dec. 15, 2017 (GLOBE NEWSWIRE) -- The American Health Council has selected Leslie Fletcher, BSN, RN, MEP-C to join the Nursing Board. She has been chosen due to her impeccable work in the field of Aesthetics. [...]

Athenex Announces Initiation of an Oral Eribulin Investigational New Drug Development Program for Oncology Indications

15/12/2017 - 14:00

Athenex has developed a novel synthetic method for Eribulin with an excellent purity profile Athenex has developed an oral version of Eribulin based on the Orascovery program which showed good oral absorption in [...]

Endocyte Added to NASDAQ Biotechnology Index

15/12/2017 - 14:00

WEST LAFAYETTE, Ind., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that it has been [...]

Ozempic® (semaglutide) recommended for approval by the European regulatory authorities

15/12/2017 - 13:13

Bagsværd, Denmark, 15 December 2017 - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has adopted a positive opinion, recommending [...]

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease

15/12/2017 - 13:12

PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease First allogeneic [...]

Takeda et TiGenix annoncent que le Cx601 (darvadstrocel) a reçu la décision favorable du CHMP dans le traitement des fistules périanales complexes de la maladie de Crohn

15/12/2017 - 13:12

COMMUNIQUE DE PRESSE INFORMATION REGLEMENTEE CONNAISSANCE PREALABLE Takeda et TiGenix annoncent que le Cx601 (darvadstrocel) a reçu la décision favorable du CHMP dans le traitement des fistules périanales complexes de [...]

Sanofi: FDA lifts clinical hold on fitusiran

15/12/2017 - 13:01

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) FDA lifts clinical hold on fitusiran Clinical trial dosing to resume around year-end 2017 Paris and Cambridge, Mass. - December 15, 2017 - Sanofi Genzyme , the [...]

Sanofi : La FDA lève la suspension des essais cliniques consacrés au fitusiran

15/12/2017 - 13:01

Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) La FDA lève la suspension des essais cliniques consacrés au fitusiran L'administration de ce médicament dans le cadre des essais cliniques qui lui sont [...]

Ohr Pharmaceutical Reports Fiscal Year 2017 Financial Results

15/12/2017 - 13:00

Management to Host a Conference Call and Webcast at 8:30 a.m. Eastern Time Today NEW YORK, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP ), a clinical-stage pharmaceutical company developing [...]

Aclaris Therapeutics Receives FDA Approval for ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses (SKs)

15/12/2017 - 13:00

ESKATA™ is the First and Only FDA-Approved Topical, Non-invasive Treatment for Raised SKs; Management to Hold Conference Call at 8:00 AM ET Today MALVERN, Pa., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc [...]

TESARO Announces Availability of ZEJULA® (niraparib) for Women With Recurrent Ovarian Cancer in Germany

15/12/2017 - 10:00

ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian cancer, without the need for BRCA testing and regardless of biomarker status ZEJULA is the only PARP inhibitor to offer once-daily, [...]

Employers, Health Plans and Providers Endorse Initiative to Standardize Performance Measures for Commercial Accountable Care Organizations (ACOs) in California

15/12/2017 - 09:01

OAKLAND, Calif., Dec. 15, 2017 (GLOBE NEWSWIRE) -- In an effort to collect more meaningful quality and cost information and reduce burden on clinicians, leading California health care purchasers, plans and providers [...]

Novartis announces Oncology head to retire

15/12/2017 - 07:01

Basel, December 15, 2017 - Novartis announced today that Bruno Strigini, CEO Novartis Oncology has decided to retire from Novartis and the industry for personal reasons. Joseph Jimenez, CEO of Novartis, said: "I'd like [...]

Beleave Provides Business Update

15/12/2017 - 02:07

TORONTO, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. (" Beleave " or the " Company ") (CSE:BE) (OTCQX:BLEVF) is pleased to announce that it has received notification from Health Canada that, upon the Company's [...]

Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae

15/12/2017 - 01:34

NEW YORK and MELBOURNE, Australia and LEUVEN, Belgium, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq: MESO ) and TiGenix NV (Euronext Brussels:TIG) (Nasdaq: TIG ) today announce that Mesoblast [...]

Resverlogix Announces Filing of Quarterly Financial Statements and Management’s Discussion & Analysis

15/12/2017 - 01:27

CALGARY, Alberta, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX ) announced today that it has filed its unaudited interim Consolidated Financial Statements and Management [...]